1.	A Master Protocol: DMSO to Enable Standard Phase II Chemotherapeutic Drugs to Pass the Blood-Brain Barrier in Treatment of Brain Tumors --- ADR, CTX Phase: Phase II Type: Treatment Status: Closed Age: 60 and under Sponsor: Protocol IDs: UMCC-8013
2.	Phase I Randomized Study of Adjuvant Transdermal Vaccine Therapy Comprising Multi-Epitope Melanoma Peptides, Tetanus Toxoid Helper Peptide, and Sargramostim (GM-CSF) in Combination With Either Montanide ISA-51 or Dimethyl Sulfoxide With or Without Imiquimod in Patients With Resected Stage II-IV Melanoma Phase: Phase I Type: Treatment Status: Closed Age: 12 and over Sponsor: NCI Protocol IDs: UVACC-MEL-45, UVACC-HIC-11490, UVACC-34204, NCT00118313
3.	Chemotherapy with Cyclophosphamide and Dimethylsulfoxide for Metastatic Epidermoid Carcinoma of the Lung Phase: No phase specified Type: Treatment Status: Closed Age: under 60 Sponsor: Protocol IDs: UMCC-7713